The Cooper (MIL:1COO) NonCurrent Deferred Liabilities: €261 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1COO The Cooper Companies Inc MIL:1COO
64 GF Score
Price €61.84
GF Value €91.34
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper NonCurrent Deferred Liabilities?

The Cooper MIL:1COO 64 NonCurrent Deferred Liabilities is €261 Mil as of Apr. 2026. GuruFocus rates MIL:1COO with a GF Score™ of 64/100 and a GF Value™ of €91.34 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

The Cooper's non-current deferred liabilities for the quarter that ended in Apr. 2026 was €261 Mil.

The Cooper NonCurrent Deferred Liabilities Related Terms

The Cooper NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for The Cooper's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper NonCurrent Deferred Liabilities Chart

The Cooper Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.86 353.42 270.56 265.58 253.49

The Cooper Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 263.00 258.13 253.49 257.60 260.95
MIL:1COO
64GF Score
The Cooper Companies Inc MIL:1COO
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of €261 Mil mean?
The Cooper (MIL:1COO) has a NonCurrent Deferred Liabilities of €261 Mil as of Apr. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on The Cooper and its competitors.
Is The Cooper's NonCurrent Deferred Liabilities too high?
The Cooper's current NonCurrent Deferred Liabilities is €261 Mil. Overall, The Cooper has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's NonCurrent Deferred Liabilities compare to SOLV and ALGN?
The Cooper's NonCurrent Deferred Liabilities of €261 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on The Cooper and its competitors. The Cooper's current NonCurrent Deferred Liabilities is €261 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (MIL:1COO) is currently considered Significantly Undervalued. The stock's GF Value™ is €91.34, compared to a current price of €61.84 — trading 32.3% below its estimated fair value. The current NonCurrent Deferred Liabilities is €261 Mil. The Cooper's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For The Cooper (MIL:1COO), the current NonCurrent Deferred Liabilities is €261 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cooper (MIL:1COO) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of €61.84 is trading 32.3% below its estimated GF Value™ of €91.34. GuruFocus considers The Cooper to be Significantly Undervalued.

Key valuation signals for MIL:1COO:

  • NonCurrent Deferred Liabilities: €261 Mil
  • GF Value™: €91.34 vs. price of €61.84 (32.3% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the MIL:1COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
64GF Score

Get the complete analysis for MIL:1COO

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€61.84
Price
€91.34
GF Value